| Literature DB >> 34947574 |
Maria João Bessa1,2,3,4, Fátima Brandão1,2,3,4, Paul H B Fokkens5, Daan L A C Leseman5, A John F Boere5, Flemming R Cassee5,6, Apostolos Salmatonidis7,8, Mar Viana7, Adriana Vulpoi9, Simion Simon9, Eliseo Monfort10, João Paulo Teixeira1,2,3, Sónia Fraga1,2,3.
Abstract
Diverse industries have already incorporated within their production processes engineered nanoparticles (ENP), increasing the potential risk of worker inhalation exposure. In vitro models have been widely used to investigate ENP toxicity. Air-liquid interface (ALI) cell cultures have been emerging as a valuable alternative to submerged cultures as they are more representative of the inhalation exposure to airborne nano-sized particles. We compared the in vitro toxicity of four ENP used as raw materials in the advanced ceramics sector in human alveolar epithelial-like cells cultured under submerged or ALI conditions. Submerged cultures were exposed to ENP liquid suspensions or to aerosolised ENP at ALI. Toxicity was assessed by determining LDH release, WST-1 metabolisation and DNA damage. Overall, cells were more sensitive to ENP cytotoxic effects when cultured and exposed under ALI. No significant cytotoxicity was observed after 24 h exposure to ENP liquid suspensions, although aerosolised ENP clearly affected cell viability and LDH release. In general, all ENP increased primary DNA damage regardless of the exposure mode, where an increase in DNA strand-breaks was only detected under submerged conditions. Our data show that at relevant occupational concentrations, the selected ENP exert mild toxicity to alveolar epithelial cells and exposure at ALI might be the most suitable choice when assessing ENP toxicity in respiratory models under realistic exposure conditions.Entities:
Keywords: DNA damage; air-liquid interface; engineered nanoparticles; genotoxicity; in vitro cytotoxicity; submerged cultures
Year: 2021 PMID: 34947574 PMCID: PMC8703991 DOI: 10.3390/nano11123225
Source DB: PubMed Journal: Nanomaterials (Basel) ISSN: 2079-4991 Impact factor: 5.076
Figure 1Aerosol generation set-up. Engineered nanoparticles (ENP) aerosols were generated by controlled injection of the ENP aqueous suspensions by means of a syringe pump to a spray nozzle were the liquid was nebulised using pre-heated compressed air. This aerosol was further dried and mixed in a nebulising cylinder connected to the Vitrocell® automated exposure station (AES). Just before entering the AES, a Teflon filter and a condensation particle counter (CPC) were connected for aerosol characterisation.
Figure 2Experimental protocol scheme. (A) Human alveolar epithelial cultures under submerged conditions were exposed for 24 h to the tested engineered nanoparticles (ENP) dispersed in serum-free incubation medium. (B) Cell cultures under air-liquid interface (ALI) conditions were exposed to either clean air or ENP aerosols using an Automated Exposure Station (AES) for 2 and 4 h to achieve different deposited doses. It was not possible to generate a stable aerosol from SnO2 NP, though they were not tested under ALI. As depicted, samples for cytotoxicity (LDH release and WST-1 metabolisation) and genotoxicity (DNA damage) assessment were collected at different timepoints.
Physicochemical characteristics of the tested engineered nanoparticles (ENP) stock suspensions.
| ENP | Hydrodynamic Size (nm) | Concentration | Oxidative Potential | Effective Density |
|---|---|---|---|---|
| SnO2 | 455.5 ± 17.98 | 2.70 × 108 | 4958 | 6.7 |
| ATO | 688.5 ± 97.80 | 12.28 × 108 | 4081 | 17.4 |
| CeO2 | 305.6 ± 79.72 | 8.07 × 108 | 4806 | 1.5 |
| ZrO2 | 406.0 ± 1.79 | 22.05 × 108 | 3408 | 3.5 |
Data are presented as mean ± SD. Hydrodynamic size was measured by Dynamic Light Scattering (DLS). Concentration was determined by Nanoparticle Tracking Analysis (NTA). Oxidative potential was measured by Electronic Spin Resonance (ERS). A.U.: arbitrary units. * Negative control (ultrapure water) = 3191 A.U.; Positive control (DOFA) = 48,041 A.U.
Aerosolisation conditions and exposure concentrations of the tested aerosolised engineered nanoparticles in human alveolar epithelial-like cultures.
| ATO | CeO2 | ZrO2 | ||
|---|---|---|---|---|
| Liquid suspension flow rate (mL/h) | 0.6 | 1.2 | 0.6 | |
| Aerosol flow through the insert (mL/min) | 25 | 25 | 25 | |
| Aerosol concentration (mg/m3) | 2.3 | 6.4 | 17.0 | |
| Number of particles | 4 × 105 | 1 × 105 | 1 × 105 | |
| Deposited mass | 2 h | 6 | 46 | 17 |
| 4 h | 12 | 92 | 34 | |
Aerosol mass concentration determined by gravimetry; Number of particles determined using a condensation particle counter (CPC); Deposited mass = mass concentration of aerosol/volume of aerosol passing through exposure chambers during exposure.
Figure 3Representative transmission electron microscopy (TEM) images of the generated aerosols (EDS spectra) with respective size distribution values. The size distribution of aerosol generated particles was determined from TEM images by using the ImageJ software.
Figure 4Cytotoxicity of the tested engineered nanoparticles (ENP) (SnO2, ATO, CeO2 and ZrO2) in human alveolar epithelial cells under submerged conditions being exposed for 24 h. Lactate dehydrogenase release (LDH) release (A) and WST-1 reduction (B) assays were carried out after 24 h exposure to the NP suspensions prepared in serum-free cell culture medium. Data are expressed as mean ± standard deviation (n = 3–4). LDH release values were normalised considering the positive control (total LDH release; cells lysed with 2% Triton X-100), while WST-1 reduction values were normalised considering the negative control. Data was analysed by the one-way analysis of variance (ANOVA) test followed by the Dunnett’s post hoc test for multiple comparisons. * p ≤ 0.05, ** p ≤ 0.01 and *** p ≤ 0.001 vs. negative control. PC: Positive control.
Figure 5Cytotoxicity of the aerosolised engineered nanoparticles (ENP) (ATO, CeO2 and ZrO2) in polarised cultures of human alveolar epithelial cells at air-liquid interface (ALI) conditions. Lactate dehydrogenase release (LDH) was assessed immediately after (0 h) (A) and at 24 h (B) after exposure. (C) WST-1 reduction assay was carried out only in the recovery period (24 h after exposure). Data are expressed as mean ± standard deviation (n = 3). LDH values were normalised considering positive control (total LDH release; cells lysed with 2% Triton X-100), while WST-1 values were normalised considering the incubator control. Data was analysed by the one-way analysis of variance (ANOVA) test followed by the Dunnett’s post hoc test for multiple comparisons. * p ≤ 0.05, ** p ≤ 0.01 and *** p ≤ 0.001 vs. Inc. Ct; $ p ≤ 0.05, $$ p ≤ 0.01 and $$$ p ≤ 0.001 vs. Exp. Ct. Inc. Ct: Incubator control; Exp. Ct: Exposure control; Positive Ct: Positive control.
Figure 6Genotoxicity of the tested engineered nanoparticles (ENP) in human alveolar epithelial cells under submerged (A,B) and ALI (C,D) conditions. Primary (A,C) and oxidative (B,D) DNA damage were assessed at 24 h after exposure to the ENP suspensions by the alkaline and FPG-modified comet assay versions, respectively. Data are expressed as mean ± standard deviation (n = 3–4). Data was analysed by one-way ANOVA followed by Dunnett’s post-hoc test. * p ≤ 0.05 and *** p ≤ 0.001 vs. negative control. # p ≤ 0.05 vs. incubator control and $ p ≤ 0.05 vs. exposure control. PC: Positive control; 500 µM MMS and 2.5 mM KBrO3 for primary (A) and oxidative (B) DNA damage under submerged conditions, respectively.
Figure 7Comet assay representative images (100× magnification) of human alveolar epithelial cells under submerged and ALI conditions exposed to the highest tested concentration of ZrO2 NP and respective experimental controls.